India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
The Indian government mandates a 500-meter distance between Jan Aushadhi Kendras in major cities to protect store viability and ensure access to affordable generic medicines. Learn about the new policy's impact.
The Supreme Court has agreed to hear SAD leader Bikram Singh Majithia's plea for bail in a drugs case. The hearing is scheduled for July 15. Read the latest legal developments.
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Delhi Police's Special Cell arrests a key drug supplier, seizing 34.4 kg of narcotics. The bust reveals a major interstate supply chain. Read the full investigation details.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
India aims to expand PrEP access by 2025 as part of its National AIDS Control Program. Learn how this HIV prevention strategy could transform public health outcomes nationwide.
Tiruvallur police dismantle sophisticated drug network spanning multiple states, arresting 16 including foreign nationals. Major drug haul seized in month-long operation.
India's drug regulator CDSCO refuses to waive local trials for lenacapavir, blocking access to revolutionary HIV prevention for 25 lakh Indians. Learn why this happens despite drug being manufactured in India.
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Indian government proposes sweeping ban on online advertisements for Schedule G, H, H1, and X drugs to combat self-medication and antimicrobial resistance. Read about the new regulatory changes.
Union Minister Bittu appeals to Himachal residents to support anti-drug campaign. Learn how communities can fight drug menace together for a safer state.
Nagaland's top police official warns drug menace could become public health emergency, calls for unified Northeast response. Golden Triangle proximity cited as major concern.
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Exclusive investigation reveals the secret journey of confiscated drugs in India's tech capital - from police vaults to scientific destruction methods that prevent environmental damage.
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
In a major crackdown on drug trafficking, Assam Police intercepts huge consignment of illegal Yaba tablets in Cachar district, arresting two key suspects in coordinated operation.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.